Literature DB >> 18552868

Interactions between CB(1) receptors and TRPV1 channels mediated by 12-HPETE are cytotoxic to mesencephalic dopaminergic neurons.

S R Kim1, E Bok, Y C Chung, E S Chung, B K Jin.   

Abstract

BACKGROUND AND PURPOSES: We recently proposed the existence of neurotoxic interactions between the cannabinoid type 1 (CB(1)) receptor and transient receptor potential vanilloid 1 (TRPV1) channels in rat mesencephalic cultures. This study seeks evidence for the mediator(s) and mechanisms underlying the neurotoxic interactions between CB(1) receptors and TRPV1 in vitro and in vivo. EXPERIMENTAL APPROACH: The mediator(s) and mechanism(s) for the interactions between CB(1) receptors and TRPV1 were evaluated by cell viability assays, immunocytochemistry, Fura-2 calcium imaging, mitochondrial morphology assay, ELISA and Western blot assay in vitro in neuron-enriched mesencephalic cultures. Injections into the substantia nigra and subsequent cell counts were also used to confirm these interactions in vivo. KEY
RESULTS: The neurotoxic interactions were mediated by 12(S)-hydroperoxyeicosatetraenoic acid (12(S)-HPETE), an endogenous TRPV1 agonist. CB(1) receptor agonists (HU210 and WIN55,212-2) increased the level of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE), a downstream metabolite of 12(S)-HPETE, which stimulates TRPV1-mediated death of mesencephalic neurons, both in vitro and in vivo. The neurotoxicity was mediated by increased intracellular Ca(2+) concentration ([Ca(2+)](i)) through TRPV1, consequently leading to mitochondrial damage and was attenuated by baicalein, a 12-lipoxygenase inhibitor. CONCLUSION AND IMPLICATIONS: Activation of CB(1) receptors in rat mesencephalic neurons was associated with biosynthesis of 12(S)-HPETE, which in turn stimulated TRPV1 activity, leading to increased [Ca(2+)](i), mitochondrial damage and neuronal death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18552868      PMCID: PMC2538702          DOI: 10.1038/bjp.2008.246

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  60 in total

1.  Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity.

Authors:  Emilce Carrasco; Diana Casper; Peter Werner
Journal:  J Neurosci Res       Date:  2005-07-01       Impact factor: 4.164

2.  Presynaptic effects of anandamide and WIN55,212-2 on glutamatergic nerve endings isolated from rat hippocampus.

Authors:  C Cannizzaro; M D'Amico; P Preziosi; M Martire
Journal:  Neurochem Int       Date:  2005-12-02       Impact factor: 3.921

3.  The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum.

Authors:  A Pintor; M T Tebano; A Martire; R Grieco; M Galluzzo; M L Scattoni; A Pèzzola; R Coccurello; F Felici; V Cuomo; D Piomelli; G Calamandrei; P Popoli
Journal:  Neuropharmacology       Date:  2006-08-08       Impact factor: 5.250

4.  Thrombin induces neurodegeneration and microglial activation in the cortex in vivo and in vitro: proteolytic and non-proteolytic actions.

Authors:  Da Yong Lee; Keun Woo Park; Byung Kwan Jin
Journal:  Biochem Biophys Res Commun       Date:  2006-06-06       Impact factor: 3.575

5.  Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo.

Authors:  Sang H Choi; Da Y Lee; Eun S Chung; Young B Hong; Seung U Kim; Byung K Jin
Journal:  J Neurochem       Date:  2005-10-07       Impact factor: 5.372

6.  R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells.

Authors:  Susanne Rösch; Robert Ramer; Kay Brune; Burkhard Hinz
Journal:  J Pharmacol Exp Ther       Date:  2005-12-05       Impact factor: 4.030

7.  Protective activation of the endocannabinoid system during ischemia in dopamine neurons.

Authors:  Miriam Melis; Giuliano Pillolla; Tiziana Bisogno; Alberto Minassi; Stefania Petrosino; Simona Perra; Anna Lisa Muntoni; Beat Lutz; Gian Luigi Gessa; Giovanni Marsicano; Vincenzo Di Marzo; Marco Pistis
Journal:  Neurobiol Dis       Date:  2006-06-08       Impact factor: 5.996

8.  Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of bcl-xL gene expression.

Authors:  Giacomo Pozzoli; Giuseppe Tringali; Mauro Vairano; Monia D'Amico; Pierluigi Navarra; Maria Martire
Journal:  J Neurosci Res       Date:  2006-05-01       Impact factor: 4.164

Review 9.  Cannabinoids, endogenous ligands and synthetic analogs.

Authors:  E Pop
Journal:  Curr Opin Chem Biol       Date:  1999-08       Impact factor: 8.822

10.  The endocannabinoid system controls key epileptogenic circuits in the hippocampus.

Authors:  Krisztina Monory; Federico Massa; Michaela Egertová; Matthias Eder; Heike Blaudzun; Ruth Westenbroek; Wolfgang Kelsch; Wolfgang Jacob; Rudolf Marsch; Marc Ekker; Jason Long; John L Rubenstein; Sandra Goebbels; Klaus-Armin Nave; Matthew During; Matthias Klugmann; Barbara Wölfel; Hans-Ulrich Dodt; Walter Zieglgänsberger; Carsten T Wotjak; Ken Mackie; Maurice R Elphick; Giovanni Marsicano; Beat Lutz
Journal:  Neuron       Date:  2006-08-17       Impact factor: 17.173

View more
  10 in total

1.  Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells.

Authors:  H Yang; Z Wang; J E Capó-Aponte; F Zhang; Z Pan; P S Reinach
Journal:  Exp Eye Res       Date:  2010-07-07       Impact factor: 3.467

2.  Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition.

Authors:  H-T Liao; H-J Lee; Y-C Ho; L-C Chiou
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

3.  Increased expression of TRPV1 in the cortex and hippocampus from patients with mesial temporal lobe epilepsy.

Authors:  Fei-Ji Sun; Wei Guo; Da-Hai Zheng; Chun-Qing Zhang; Song Li; Shi-Yong Liu; Qing Yin; Hui Yang; Hai-Feng Shu
Journal:  J Mol Neurosci       Date:  2012-08-31       Impact factor: 3.444

4.  Inhibition of renin release by arachidonic acid metabolites, 12(s)-HPETE and 12-HETE: role of TRPV1 channels.

Authors:  Chaoqin Xie; Donna H Wang
Journal:  Endocrinology       Date:  2011-08-16       Impact factor: 4.736

5.  Interaction Between the Cannabinoid and Vanilloid Systems on Anxiety in Male Rats.

Authors:  Nafiseh Faraji; Alireza Komaki; Iraj Salehi
Journal:  Basic Clin Neurosci       Date:  2017 Mar-Apr

Review 6.  Corneal Nerve Fiber Structure, Its Role in Corneal Function, and Its Changes in Corneal Diseases.

Authors:  Hiroshi Eguchi; Akio Hiura; Hiroshi Nakagawa; Shunji Kusaka; Yoshikazu Shimomura
Journal:  Biomed Res Int       Date:  2017-11-07       Impact factor: 3.411

7.  Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson's Disease.

Authors:  Rayul Wi; Young Cheul Chung; Byung Kwan Jin
Journal:  J Immunol Res       Date:  2020-09-28       Impact factor: 4.818

Review 8.  The Role of TRP Channels and PMCA in Brain Disorders: Intracellular Calcium and pH Homeostasis.

Authors:  Sung-Min Hwang; Ji Yeon Lee; Chul-Kyu Park; Yong Ho Kim
Journal:  Front Cell Dev Biol       Date:  2021-01-28

Review 9.  Potential of Endocannabinoids to Control Bladder Pain.

Authors:  Dale E Bjorling; Zun-Yi Wang
Journal:  Front Syst Neurosci       Date:  2018-05-15

10.  TRPV1 Hyperfunction Involved in Uremic Toxin Indoxyl Sulfate-Mediated Renal Tubular Damage.

Authors:  Chien-Lin Lu; Chun-Hou Liao; Kuo-Cheng Lu; Ming-Chieh Ma
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.